Krystal Biotech, Inc. KRYS Europe — Product revenue, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s europe — product revenue, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s europe — product revenue, net?
- Krystal Biotech, Inc. (KRYS) reported europe — product revenue, net of $20.68M in Q1 2026.
- What does europe — product revenue, net mean?
- The total net income earned from selling products in the European market.
- How do you interpret europe — product revenue, net?
- An increase indicates successful market penetration, strong product adoption, or effective commercial execution in Europe, while a decrease may signal competitive pressure, regulatory hurdles, or pricing challenges.
- How does europe — product revenue, net compare across companies?
- Comparable to regional revenue reporting for other biotechnology firms with international commercial operations, often benchmarked against total global revenue to assess geographic diversification.